New inhaled powder for COPD heads into first human tests
NCT ID NCT07567872
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests an inhaled powder called HRS-9821 in healthy volunteers and people with COPD. The main goal is to check safety and how the body handles the drug. About 48 participants will receive either the drug or a placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HRS-9821 powder for inhalation
What this could lead to
If successful, this could lead to a new inhaled treatment option for COPD that helps control the disease.
What could go wrong
This is a very early Phase 1 trial with only 48 participants, focused on safety. It is too small and early to know if the drug will work or be safe long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610044, China
Contact
Contact